Biogen's Trading Volume Drops 46.4% to $260 Million, Ranks 363rd in Daily Volume

On March 24, 2025, Biogen's trading volume reached $260 million, marking a 46.4% decrease from the previous day. This placed Biogen at the 363rd position in terms of trading volume for the day. The stock price of Biogen increased by 0.50%.

Biogen has announced its plans to establish a new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, Massachusetts. This move is part of a multi-year real estate consolidation plan aimed at modernizing its facilities and centralizing its presence in Kendall Square. The new headquarters will integrate Biogen's research and development, technical operations, and commercial organizations into a co-located innovation hub. The facility is scheduled to open in 2028, coinciding with Biogen's 50th anniversary, and will commemorate five decades of scientific discovery and clinical development.

Christopher A. Viehbacher, President and Chief Executive Officer at Biogen, highlighted the significance of this new chapter for the company, emphasizing how the new space will support the advancement of Biogen's pipeline of breakthrough medicines by fostering collaboration with leading scientific minds, key partners, and top talent. The new headquarters will feature state-of-the-art laboratories, upgraded workspaces, and modern amenities, along with sustainable design elements such as advanced water conservation measures and energy-efficient systems.

Biogen has signed a 15-year lease for approximately 580,000 square feet of office and research and development space as part of the Kendall Common development project. The lease agreement is with a joint venture partnership between MIT Investment Management Company and BioMed Realty, a Blackstone Real Estate portfolio company. Biogen plans to be the sole corporate tenant in the building, allowing the company to optimize its real estate footprint in Cambridge and create a purpose-built innovation hub designed to foster increased collaboration among employees and external partners.

The new building will also house the Biogen CoLab, a classroom-style community laboratory and collaborative space where Biogen scientists, nonprofits, schools, and universities will come together to help students and career-ready adults discover and prepare for careers in life science and healthcare. The Biogen CoLab is intended to serve as a gateway to Biogen and a central engine of talent generation and dynamic co-creation.